Analysis of the evolution, infectivity and antigenicity of circulating rabies virus strains.

Rabies virus antigenic evolution genetic evolution infectivity

Journal

Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885

Informations de publication

Date de publication:
Dec 2022
Historique:
pubmed: 17 5 2022
medline: 7 6 2022
entrez: 16 5 2022
Statut: ppublish

Résumé

Rabies virus has existed for thousands of years and is circulating in many species. In the present study, a total of 2896 rabies viruses isolated worldwide were phylogenetically classified into ten clusters based on the G gene sequence, and these clusters showed a close relationship with the hosts and regions that they were isolated from. Eighty-three representative G sequences were selected from ten clusters and were used to construct pseudoviruses using the VSV vector. The phylogenetic relationships, infectivity and antigenicity of the representative 83 pseudotyped rabies viruses were comprehensively analyzed. Eighty three pseudoviruses were divided into four antigentic clusters (GAgV), of which GAgV4 showed poor neutralization to all immunized sera. Further analysis showed that almost all strains in the GAgV4 were isolated from wild animals in the America, especially bats and skunks. No significant relationship in terms of phylogeny, infectivity and antigenicity was proved. Amino acid mutations at residues 231and 436 can affect the infectivity, while mutations at residues 113, 164 and 254 may affect the sensitivity to immunized animal sera, especially residue 254. We recommend close monitoring of infectivity and antigenicity, which should be more precise than simple genetic analysis.

Identifiants

pubmed: 35570580
doi: 10.1080/22221751.2022.2078742
pmc: PMC9176641
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1474-1487

Références

Emerg Infect Dis. 2014 Sep;20(9):1433-42
pubmed: 25144604
J Gen Virol. 1994 Oct;75 ( Pt 10):2575-83
pubmed: 7931145
Science. 2004 Jul 16;305(5682):371-6
pubmed: 15218094
Front Microbiol. 2020 Apr 03;11:481
pubmed: 32308648
Cell Host Microbe. 2020 Mar 11;27(3):441-453.e7
pubmed: 32004500
J Gen Virol. 1999 Oct;80 ( Pt 10):2545-2557
pubmed: 10573146
Virus Res. 2009 Sep;144(1-2):215-24
pubmed: 19442690
Nature. 1981 Feb 26;289(5800):765-71
pubmed: 7464941
Vet Q. 2017 Dec;37(1):212-251
pubmed: 28643547
Virus Res. 2013 May;173(2):415-20
pubmed: 23318595
Virology. 1993 May;194(1):70-81
pubmed: 8386891
J Clin Microbiol. 1996 Jun;34(6):1553-8
pubmed: 8735118
J Clin Microbiol. 2006 May;44(5):1697-710
pubmed: 16672396
Emerg Infect Dis. 2008 Dec;14(12):1887-9
pubmed: 19046512
Expert Rev Vaccines. 2003 Jun;2(3):399-406
pubmed: 12903805
J Neuropathol Exp Neurol. 1983 Jul;42(4):439-52
pubmed: 6864237
Adv Ther. 2007 Nov-Dec;24(6):1340-7
pubmed: 18165217
J Am Vet Med Assoc. 2020 Feb 15;256(4):438-443
pubmed: 31999515
Virology. 2002 Jan 20;292(2):247-57
pubmed: 11878928
Gene Ther. 2015 May;22(5):357-64
pubmed: 25630949
Infect Genet Evol. 2009 Jan;9(1):87-96
pubmed: 19041424
J Gen Virol. 2007 Mar;88(Pt 3):967-980
pubmed: 17325371
Virus Res. 2005 May;109(2):139-47
pubmed: 15763144
Proc Natl Acad Sci U S A. 1986 Jun;83(11):3914-8
pubmed: 3459163
Virus Res. 2006 May;117(2):215-26
pubmed: 16303200
Virus Res. 2006 Sep;120(1-2):113-20
pubmed: 16701914
Virus Res. 2010 Oct;153(1):100-5
pubmed: 20637811
Virus Res. 2001 Apr;74(1-2):139-56
pubmed: 11226582
Vet Microbiol. 2005 May 20;107(3-4):161-70
pubmed: 15863275
Arch Virol. 1997;142(5):1011-9
pubmed: 9191865
J Clin Virol. 2010 Sep;49(1):47-52
pubmed: 20650678
Rev Saude Publica. 1995 Oct;29(5):393-7
pubmed: 8731280
Virol Sin. 2012 Oct;27(5):299-302
pubmed: 23055005
J Vet Sci. 2011 Mar;12(1):57-63
pubmed: 21368564
Microbiol Immunol. 2007;51(9):833-40
pubmed: 17895600
Cell. 2020 Sep 3;182(5):1284-1294.e9
pubmed: 32730807
Nat Rev Microbiol. 2018 Apr;16(4):241-255
pubmed: 29479072
Epidemiol Infect. 2012 Dec;140(12):2157-62
pubmed: 22458941
Microbes Infect. 2010 Nov;12(12-13):948-55
pubmed: 20601078
Acta Trop. 2020 Jul;207:105461
pubmed: 32243880
Emerg Microbes Infect. 2019;8(1):1584-1592
pubmed: 31682199
Sci Rep. 2015 Sep 28;5:14171
pubmed: 26412348
Vet Microbiol. 2011 Aug 26;152(1-2):181-6
pubmed: 21571453
Virology. 2008 Jan 20;370(2):228-36
pubmed: 17996263
Virus Genes. 2008 Jun;36(3):449-59
pubmed: 18363090
Cells. 2020 Feb 11;9(2):
pubmed: 32053954
Virus Res. 2003 Nov;97(2):65-79
pubmed: 14602198
J Virol. 2001 Sep;75(17):8096-104
pubmed: 11483755

Auteurs

Meina Cai (M)

Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Graduate School of Peking Union Medical College, Beijing, People's Republic of China.

Haizhou Liu (H)

National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People's Republic of China.
CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.

Fei Jiang (F)

Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.

Yeqing Sun (Y)

Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.

Wenbo Wang (W)

Division of Monoclonal Antibody Products, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.

Yimeng An (Y)

Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.

Mengyi Zhang (M)

Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.

Xueli Li (X)

Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.

Di Liu (D)

National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People's Republic of China.
CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.

Yuhua Li (Y)

Department of Arboviral Vaccine, National Institutes for Food and Drug Control, (NIFDC), Beijing, People's Republic of China.

Yongxin Yu (Y)

Department of Arboviral Vaccine, National Institutes for Food and Drug Control, (NIFDC), Beijing, People's Republic of China.

Weijin Huang (W)

Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.

Youchun Wang (Y)

Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Graduate School of Peking Union Medical College, Beijing, People's Republic of China.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH